SiNtx Technologies Inc (SINT)

[boston745]

2nd gen is not a "NEW" material its a modification of the first gen. You do understand that companies always strive to improve their products right?

For example we develop the second generation material by just changing some manufacturing steps just last year. This new material, which is still silicon nitride with the surface chemistry alerted show the three-fold greater bone affinity in our early studies, which is absolutely remarkable considering the already excellent natural affinity of our existing silicon nitride for bone cells.

Now enhancing bone fusion and bone healing has been a dream of orthopedic surgeons introduce us to material strategies is a big cost advantage in the healthcare system especially in today’s cost conscious world. The surface engineering of a biomaterial to enhance specific bioactivity targeted at clinical solutions is a novel strategy, pioneered by Amedica and very well received at every scientific forum so far while we have presented our data.

Q1'16 CC